文献速递儿科影像骨肌MR

表观扩散系数图直方图分析提供儿童及青年横纹肌肉瘤的基因型和治疗前表型信息

Histogram Analysis of Apparent Diffusion Coefficient Maps Provides Genotypic and Pretreatment Phenotypic Information in Pediatric and Young Adult Rhabdomyosarcoma.
PubMed 文献 · Acad Radiol · 2024-01-30

该回顾性研究评估了38例儿童及青年横纹肌肉瘤患者基线扩散加权成像的ADC直方图指标,发现10百分位数可区分腺泡型与胚胎型横纹肌肉瘤(AUC 0.85)及FOXO1融合阳性与阴性(AUC 0.83),熵可区分TNM分期1期与≥2期(AUC 0.8)及低危与中/高危(AUC 0.9)。

要点

  • ADC直方图10百分位数可区分腺泡型与胚胎型横纹肌肉瘤,AUC为0.85。
  • ADC直方图10百分位数可区分FOXO1融合阳性与阴性横纹肌肉瘤,AUC为0.83。
  • ADC直方图熵可区分TNM分期1期与≥2期(AUC 0.8)及低危与中/高危(AUC 0.9)。

核心结论

  • ADC直方图指标有潜力预测横纹肌肉瘤的临床相关变量,包括FOXO1融合状态、组织病理学、临床分组、TNM分期和风险分层。

研究设计与样本

  • 回顾性评估38例横纹肌肉瘤患者(胚胎型21例、腺泡型13例、梭形细胞型2例、未另作分类2例;平均年龄8.1±7.76岁)的基线扩散加权成像,图像来自多站点多种1.5 T和3 T扫描仪,基于手动肿瘤勾画获取全肿瘤ADC图直方图参数。

诊断标准与关键数值

  • 腺泡型横纹肌肉瘤10百分位数为586.54±164.52×10⁻⁶mm²/s,低于胚胎型横纹肌肉瘤的966.51±481.33×10⁻⁶mm²/s,鉴别两者AUC为0.85(95%CI 0.73-0.95)。
  • FOXO1融合阳性横纹肌肉瘤10百分位数为553.87±187.64×10⁻⁶mm²/s,低于融合阴性者的898.07±449.38×10⁻⁶mm²/s,鉴别两者AUC为0.83(95%CI 0.71-0.94)。
  • 评估的18个直方图参数中分别有4个、5个和7个随TNM分期、临床分组和预处理风险分层升高而呈统计学显著增加。
  • 熵鉴别TNM分期1期与≥2期的AUC为0.8(95%CI 0.67-0.92),鉴别低危与中/高危分层的AUC为0.9(95%CI 0.8-0.98)。

临床应用与阅片要点

  • 作者认为ADC直方图指标有潜力预测横纹肌肉瘤的FOXO1融合状态、组织病理学、临床分组、TNM分期和风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: We evaluate the role of apparent diffusion coefficient (ADC) histogram metrics in stratifying pediatric and young adult rhabdomyosarcomas.

METHODS: We retrospectively evaluated baseline diffusion-weighted imaging (DWI) from 38 patients with rhabdomyosarcomas (Not otherwise specified: 2; Embryonal: 21; Spindle Cell: 2; Alveolar: 13, mean ± std dev age: 8.1 ± 7.76 years). The diffusion images were obtained on a wide range of 1.5 T and 3 T scanners at multiple sites. FOXO1 fusion status was available for 35 patients, nine of whom harbored the fusion. 13 patients were TNM stage 1, eight had stage 2 disease, nine were stage 3, and eight had stage 4 disease. 23 patients belonged to Clinical Group III and seven to Group IV, while two and five were CG I and II, respectively. Nine patients were classified as low risk, while 21 and five were classified as intermediate and high risk respectively. Histogram parameters of the apparent diffusion coefficient (ADC) map from the entire tumor were obtained based on manual tumor contouring. A two-tailed Mann-Whitney U test was used for all two-group, and the Kruskal-Wallis's test was used for multiple-group comparisons. Bootstrapped receiver operating characteristic (ROC) curves and areas under the curve (AUC) were generated for the statistically significant histogram parameters to differentiate genotypic and phenotypic parameters.

RESULTS: Alveolar rhabdomyosarcomas had a statistically significant lower 10th Percentile (586.54 ± 164.52, mean ± std dev, values are in ×10-6mm2/s) than embryonal rhabdomyosarcomas (966.51 ± 481.33) with an AUC of 0.85 (95%CI. 0.73-0.95) for differentiating the two. The 10th percentile was also significantly different between FOXO1 fusion-positive (553.87 ± 187.64) and negative (898.07 ± 449.38) rhabdomyosarcomas with an AUC of 0.83 (95% CI 0.71-0.94). Alveolar rhabdomyosarcomas also had statistically significant lower Mean, Median, and Root Mean Squared ADC histogram values than embryonal rhabdomyosarcomas. Four, five, and seven of the 18 histogram parameters evaluated demonstrated a statistically significant increase with higher TNM stage, clinical group, assignment, and pretreatment risk stratification, respectively. For example, Entropy had an AUC of 0.8 (95% CI. 0.67-0.92) for differentiating TNM stage 1 from ≥ stage 2 and 0.9 (95% CI. 0.8-0.98) for differentiating low from intermediate or high-risk stratification.

CONCLUSION: Our findings demonstrate the potential of ADC histogram metrics to predict clinically relevant variables for rhabdomyosarcoma, including FOXO1 fusion status, histopathology, Clinical Group, TNM staging, and risk stratification.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ghosh A, Li H, Towbin AJ, et al. Histogram Analysis of Apparent Diffusion Coefficient Maps Provides Genotypic and Pretreatment Phenotypic Information in Pediatric and Young Adult Rhabdomyosarcoma. Acad Radiol. 2024. PMID: 38296742. doi:10.1016/j.acra.2024.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。